Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas.

Jong Chul ParkTing Martin MaLisa RooperTodd HembroughRobert D FossNicole C SchmittRishi SawhneyAaron FlandersHyunseok Kang

Published in: Head & neck (2018)

Dual HER2 blockage resulted in CR in patients with HER expressing salivary duct carcinoma and warrants further evaluation in this patient population.

Keyphrases